X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Details:
Dermacyte (human amniotic fluid), a cell-free amniotic injection, that is being developed in Phase 2 clinical trial for the treatment of venous stasis ulcer.
Lead Product(s): Human Amniotic Fluid
Therapeutic Area: Cardiology/Vascular Diseases Product Name: Dermacyte
Highest Development Status: Phase IIProduct Type: Large molecule
Partner/Sponsor/Collaborator: Not Applicable
Deal Size: Not Applicable Upfront Cash: Not Applicable
Deal Type: Not Applicable December 05, 2023
Details:
Dermacyte® Amniotic Wound Care Liquid (human amniotic fluid), a cell-free amniotic injection that is being developed under Merakris’ investigational New Drug (IND) approval for would healing.
Lead Product(s): Human Amniotic Fluid
Therapeutic Area: Trauma (Emergency, Injury, Surgery) Product Name: Dermacyte Liquid
Highest Development Status: IND EnablingProduct Type: Cell and Gene therapy
Partner/Sponsor/Collaborator: Not Applicable
Deal Size: Not Applicable Upfront Cash: Not Applicable
Deal Type: Not Applicable November 29, 2022
Details:
Merakris has entered into a Cooperative Research and Development Agreement with the VA and is currently negotiating with additional clinical sites to conduct the two-part Phase II clinical trial for Dermacyte, Human Amniotic Fluid.
Lead Product(s): Human Amniotic Fluid
Therapeutic Area: Cardiology/Vascular Diseases Product Name: Dermacyte
Highest Development Status: Phase IIProduct Type: Cell and Gene therapy
Partner/Sponsor/Collaborator: US Department of Veterans Affairs
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Agreement July 27, 2022
Details:
A single combination treatment with Dermacyte Liquid and Dermacyte Matrix (Human Amniotic Fluid) healed smaller of two wounds in four weeks. Dermacyte Liquid was injected under skin around wounds on patient’s thigh and lower leg.
Lead Product(s): Human Amniotic Fluid
Therapeutic Area: Cardiology/Vascular Diseases Product Name: Dermacyte Liquid
Highest Development Status: Phase IIProduct Type: Cell and Gene therapy
Partner/Sponsor/Collaborator: The University of Texas MD Anderson Cancer Center
Deal Size: Not Applicable Upfront Cash: Not Applicable
Deal Type: Not Applicable June 02, 2022
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] 
Market Place
